Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03425006 |
|
Recruitment Status :
Terminated
(Administrative reasons)
First Posted : February 7, 2018
Last Update Posted : May 27, 2022
|
Sponsor:
University of Pennsylvania
Information provided by (Responsible Party):
University of Pennsylvania
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | June 17, 2021 |
| Actual Study Completion Date : | October 11, 2021 |
| Certification/Extension First Submitted : | May 24, 2022 |